House Panel Blocks Cannabis Rescheduling Despite Trump Push
Congressional committee votes to halt DEA rescheduling efforts as Trump administration signals support for reform, creating regulatory uncertainty.
A House committee voted to block federal marijuana rescheduling efforts, directly challenging the Trump administration's apparent support for moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. The committee action creates a legislative roadblock for the Drug Enforcement Administration's ongoing rescheduling process, which began under the Biden administration and has continued into Trump's second term.
The congressional intervention highlights the complex political dynamics surrounding cannabis reform, where traditional party lines blur on drug policy. While Trump has signaled openness to rescheduling—a shift from his previous administration's approach—House Republicans remain split on federal cannabis policy. The committee's vote demonstrates that even with executive branch support, legislative opposition can stall regulatory progress.
Rescheduling cannabis to Schedule III would provide substantial tax relief for state-licensed operators currently barred from standard business deductions under Section 280E of the tax code. Multi-state operators like Curaleaf Holdings (CURLF), Green Thumb Industries (GTBIF), and Trulieve Cannabis (TCNNF) have built their business models anticipating this tax burden relief, which could boost profit margins by 15-25% across the sector.
The regulatory uncertainty creates a challenging environment for cannabis investors weighing federal reform timelines against state market expansion opportunities. While 38 states have legalized medical cannabis and 24 permit adult-use sales, federal prohibition continues to limit banking access, interstate commerce, and institutional investment flows into the sector.
The committee's blocking action may delay rescheduling by months or years, forcing cannabis companies to maintain current operational strategies focused on state-by-state market development rather than federal integration. This prolonged timeline particularly impacts smaller operators with limited capital reserves, while larger MSOs with established cash flows can better weather extended federal prohibition periods.